Skip to content

BCBS North Dakota

Does BCBS North Dakota cover Zepbound?

Yes. BCBS North Dakota covers Zepbound for weight loss with prior authorization if your BMI is 30 or higher, or 27 or higher with a related condition. Other policy requirements and your plan's benefits also apply.

Policy document

  • Employer and ACA Marketplace: Covered with requirements. See the qualification pathways below.

Earliest policy review June 2, 2026. How we verify · Check your exact plan

Full requirements: Zepbound for Weight Loss (2 plan types)

Applies to Employer and ACA Marketplace plans.

Covered with requirements

Qualification pathways

You can qualify through any one of these.

Adult obesity without comorbidity

All of:

  • BMI ≥ 30 kg/m2
  • Inadequate response to comprehensive lifestyle intervention program

Adult overweight with comorbidity

All of:

  • BMI ≥ 27 kg/m2
  • Inadequate response to comprehensive lifestyle intervention program

Plus any one of:

  • Hypertension
  • Type 2 diabetes
  • Dyslipidemia
  • Obstructive sleep apnea
  • Cardiovascular disease
  • Other weight-related comorbid condition

Documentation to bring

  • Documentation of BMI ≥ 30 kg/m2 or ≥ 27 kg/m2 with at least one weight-related comorbidity
  • Documentation of prior comprehensive lifestyle intervention program attempt or reason it is not feasible
  • Documentation of weight-related comorbid condition if BMI is 27-29.9 kg/m2

Approval and renewal

  • Renewal: Per referenced guidelines, if weight loss ≥ 5% of body weight at 3 months, medication should be continued. If weight loss < 5% at 3 months or safety/tolerability issues, medication should be discontinued.
  • Renewal: At least 12 weeks on therapy before the first renewal.

Not covered when

  • Coadministration with other tirzepatide-containing products is not recommended
  • Coadministration with any GLP-1 receptor agonist is not recommended

Policy note: Zepbound is available as subcutaneous injection vial and KwikPen formulations. FDA indication is for adults only. Full PA criteria details beyond FDA indication summary and referenced guidelines are not enumerated in the provided document text.

Policy effective April 20, 2026 · verified June 2, 2026 · source: Nd Weight Management Paql Prog Sum · View policy document (PDF)

Open on its own page →

Full requirements: Zepbound for Obstructive Sleep Apnea (OSA) (2 plan types)

Applies to Employer and ACA Marketplace plans.

Covered with requirements

Qualification pathways

You can qualify through any one of these.

Moderate to severe OSA in adults with obesity

All of:

  • Adult patient (age ≥ 18)
  • Diagnosis of moderate to severe obstructive sleep apnea (OSA)
  • Obesity (BMI ≥ 30 kg/m2)

Documentation to bring

  • Documentation of moderate to severe OSA diagnosis
  • Documentation of obesity (BMI ≥ 30 kg/m2)

Not covered when

  • Coadministration with other tirzepatide-containing products is not recommended
  • Coadministration with any GLP-1 receptor agonist is not recommended

Policy note: FDA indication listed as moderate to severe OSA in adults with obesity. Specific AHI threshold, PAP trial requirement, and other OSA-specific PA criteria are not enumerated in the provided document text — only the FDA indication summary is presented. Document does not specify 'moderate to severe' in terms of AHI cutoff values.

Policy effective April 20, 2026 · verified June 2, 2026 · source: Nd Weight Management Paql Prog Sum · View policy document (PDF)

Open on its own page →

Questions people ask
Does BCBS North Dakota cover Zepbound?
Yes. BCBS North Dakota covers Zepbound for weight loss with prior authorization if your BMI is 30 or higher, or 27 or higher with a related condition. Other policy requirements and your plan's benefits also apply.
What does BCBS North Dakota require to renew Zepbound?
Weight Loss — Applies to Employer and ACA Marketplace plans. Per referenced guidelines, if weight loss ≥ 5% of body weight at 3 months, medication should be continued. If weight loss < 5% at 3 months or safety/tolerability issues, medication should be discontinued. At least 12 weeks on therapy before the first renewal.
How current is this information?
The oldest review date among the policies on this page is June 2, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

Also under BCBS North Dakota: Mounjaro, Ozempic, Wegovy

Zepbound under other plans: North Dakota Medicaid, BCBS Alabama, BCBS Arizona, BCBS Arkansas, BCBS Massachusetts, BCBS Michigan, BCBS Minnesota, BCBS Nebraska

All insurance plans · All medications

Summary of BCBS North Dakota's written policy, not a guarantee of coverage. Plans vary by employer and benefit design.